Editas Medicine
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $30,604 | $61 | $513 | $1,135 |
Gross Profit | 30,604 | -1,538 | -907 | -274 |
EBITDA | -32,980 | -60,542 | -70,483 | -65,581 |
EBIT | -34,361 | -62,141 | -71,903 | -66,990 |
Net Income | -45,395 | -62,141 | -67,607 | -61,950 |
Net Change In Cash | 30,604 | 61 | 513 | 1,135 |
Free Cash Flow | -51,302 | -55,509 | -60,556 | -51,743 |
Cash | 131,541 | 95,832 | 64,441 | 69,227 |
Basic Shares | 82,613 | 82,485 | 82,310 | 81,938 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $32,314 | $78,123 | $19,712 | $25,544 |
Gross Profit | 32,314 | -99,528 | 19,712 | 25,544 |
EBITDA | -233,111 | -163,117 | -219,613 | -188,093 |
EBIT | -238,920 | -169,181 | -225,950 | -193,146 |
Net Income | -237,093 | -153,219 | -204,352 | -185,107 |
Net Change In Cash | 32,314 | 78,123 | 19,712 | 25,544 |
Cost of Revenue | -61,997 | 63,837 | ||
Free Cash Flow | -219,110 | -136,897 | -181,467 | -171,780 |
Cash | 131,541 | 123,652 | 141,522 | 203,519 |
Basic Shares | 82,338 | 75,965 | 68,664 | 67,619 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.55 |
2024-09-30 | -$0.75 |
2024-06-30 | -$0.82 |
2024-03-31 | -$0.76 |
